| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| MIR127 |
|
microRNA 127
|
|
|
0.553 |
0.692 |
| CYP2D6 |
P10635
|
cytochrome P450 family 2 subfamily D member 6
|
|
1.1E-25 |
0.437 |
0.885 |
| SCN9A |
Q15858
|
sodium voltage-gated channel alpha subunit 9
|
Ion channel
|
4.8E-19 |
0.543 |
0.615 |
| RBM45 |
Q8IUH3
|
RNA binding motif protein 45
|
|
2.1E-10 |
0.383 |
0.846 |
| CPS1 |
P31327
|
carbamoyl-phosphate synthase 1
|
Enzyme
|
1.1E-09 |
0.590 |
0.615 |
| VPS51 |
Q9UID3
|
VPS51 subunit of GARP complex
|
|
1.1E-08 |
0.452 |
0.846 |
| AGT |
P01019
|
angiotensinogen
|
Enzyme modulator
|
5.0E-08 |
0.367 |
0.923 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
| NCR3 |
O14931
|
natural cytotoxicity triggering receptor 3
|
|
3.7E-04 |
0.638 |
0.769 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
| CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
| AGTR2 |
P50052
|
angiotensin II receptor type 2
|
G-protein coupled receptor
|
8.2E-03 |
0.496 |
0.808 |
| ALB |
P02768
|
albumin
|
Transporter
|
0.64 |
0.317 |
0.962 |
| BDNF |
P23560
|
brain derived neurotrophic factor
|
Signaling
|
0.66 |
0.345 |
0.923 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| NGF |
P01138
|
nerve growth factor
|
Signaling
|
0.82 |
0.391 |
0.885 |
| ANGPT2 |
O15123
|
angiopoietin 2
|
Signaling
|
0.83 |
0.410 |
0.846 |
| GCH1 |
P30793
|
GTP cyclohydrolase 1
|
Enzyme
|
0.90 |
0.511 |
0.846 |
| NTN1 |
O95631
|
netrin 1
|
Enzyme modulator
|
1.00 |
0.509 |
0.846 |
| SCN8A |
Q9UQD0
|
sodium voltage-gated channel alpha subunit 8
|
Ion channel
|
1.00 |
0.510 |
0.731 |